Abbott & ISN Partner to Transform Private Healthcare Testing in Nigeria
Set for Medical Equipment Placement
Abbott has recently on boarded ISN as an authorized distributor to manage the needs of private healthcare institutions across Nigeria. This partnership is designed to make Abbott’s innovative diagnostics more accessible, affordable, and sustainable for healthcare providers.
As part of this collaboration, Abbott and ISN are launching a strategic nationwide project to deploy 50 m-PIMA™ machines in 50 private healthcare facilities, including laboratories.
This project is proudly supported by the Guild of Medical Laboratory Directors (GMLD) Nigeria under the leadership of the President, Dr Samuel Fele. Dr Fele believes that this Abbott project is the way to go and the members of GMLD nationwide should embrace the gesture. He further assured his members of more collaborations that will make the laboratory profession a seamless process.
Dr Samuel Fele
National President GMLD
What is the m-PIMA™?
The Abbott m-PIMA™ is a portable, point-of-care molecular diagnostic platform designed for rapid and accurate detection of HIV viral load and Early Infant Diagnosis (EID).
Unlike conventional laboratory systems that can take several weeks to months for results, the m-PIMA™ delivers lab-quality results in less than an hour—empowering healthcare providers to make timely, life-saving decisions. It is also equipped with an external battery that lasts up to 12 hours without electricity, making it highly reliable even in areas where power supply is unstable.
Abbott: A Legacy of Innovation
Abbott has been a global leader in healthcare for over a century, consistently manufacturing innovative, high-quality diagnostic solutions. The m-PIMA™ continues this tradition—combining advanced science, portability, and user-friendly design to meet today’s healthcare challenges.
Key Benefits of the Initiative:
Rapid Turnaround Time
Cut HIV viral load and EID testing from weeks or months to under one hour, enabling same-day decisions and faster treatment initiation.
Huge patient referral due to collaboration with government facilities.
Exclusive Discounts on Abbott Products.
Gain access to huge discounts on the full range of Abbott’s WHO pre-qualified diagnostic products, ensuring affordability without compromising quality.
Flexible Payment Plan
Equipment will be provided on a placement basis with only 10% upfront payment. The balance can be spread over an agreed period, with full ownership transferred to the facility upon completion of payment.
Free Technical Support
Enjoy free installation, training, and maintenance from the joint Abbott/ISN technical team to guarantee smooth operations.
Why This Matters Now
With changes in global funding priorities—such as recent shifts in U.S. support under the Trump administration—Nigeria’s private healthcare sector must step up to complement public healthcare services. Many patients, especially those facing stigma-related conditions like HIV and hepatitis, prefer seeking treatment in private facilities.
Portability for Greater Reach
The m-PIMA™ is lightweight and easy to transport, making it perfect for use outside traditional laboratories. Its 12-hour battery life allows testing in locations without steady electricity—such as during outreach in IDP camps, remote rural communities, or even in the homes of patients who request discreet, private care.
This initiative reinforces Abbott’s long-term commitment to strengthening Nigeria’s private healthcare capacity, improving diagnostic access, and delivering cutting-edge technology where it is needed most.
This is your opportunity to be among the last 50 facilities to receive the m-PIMA™ and lead the way in faster, more reliable patient care.
📞 Contact Us Immediately
Slots are limited to the final 50 facilities nationwide — secure yours today.+234 813 728 5576 or +2348146942208 Maxwell Tillo.